NorthWest Biotherapeutics Inc (NWBO)

[CogDiss 1188X]

The use of the word cure regarding cancer is a bit of a delicate issue. Here are some professional perspectives:

Dana Farber oncologists were surveyed regarding whether they use of the word “cure.”

81% were hesitant to tell a patient that they are cured, and 63% would never tell a patient that they are cured. Only 7% felt that greater than 75% of their patients are, or will be, cured. The participating clinicians reported that only 34% of patients ask if they are cured. For 20-year survivors of testicular cancer, large-cell lymphoma, and estrogen receptor–positive breast cancer, 84%, 76%, and 48% of clinicians, respectively, believed that the patients were cured, and 35%, 43%, and 56% recommended annual oncology follow-up of the patients.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3710180/

More on breast cancer specifically:

After 5 years of adjuvant endocrine therapy, breast-cancer recurrences continued to occur steadily throughout the study period from 5 to 20 years. The risk of distant recurrence was strongly correlated with the original TN status, with risks ranging from 10 to 41%, depending on TN status and tumor grade.

Odds which argue against the use of the word cure.

See the “Statement” of the Siracusa Charter half way down the following article if you really want to get wonky and slice the issue into 9 shades of grey:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4324351/

Note to Ex: no video replies!